Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059351) titled 'Effect of Imidazole Dipeptide Supplementation on Lipid Metabolism During Aerobic Exercise' on Oct. 9.
Study Type: Interventional
Study Design:
Parallel Randomized
Primary Sponsor: Daito Bunka University
Condition:
healthy individuals
Intervention:
Participants will consume 2.0 g of imidazole dipeptides or placebo daily for four weeks.
Participants will consume 2.0 g of imidazole dipeptides or placebo daily for four weeks....
Recruitment Status: Not Recruiting
Phase: Not applicable
Date of First Enrollment: 2025/09/22
Target Sample Size: 30
Countries of Recruitment:
Japan
To know more, visit htt...